MetaVia Inc. — Director's Dealing 2019

Jul 26, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gemphire Therapeutics Inc. (GEMP)
CIK: 0001638287
Period of Report: 2019-07-24

Reporting Person: Bisgaier Charles PhD (Director, Chief Scientific Off. & Chair, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-24	Common Stock	A	100000	—	Acquired	1348914	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	82220	Indirect
Common Stock	19228	Indirect

Footnotes

F1: These shares are indirectly owned by the reporting person as trustee of The Charles L. Bisgaier Trust.